Avatrombopag is a medication that belongs to a class of drugs known as thrombopoietin receptor agonists. It is used to treat low platelet counts in patients with chronic liver disease who are undergoing a medical procedure such as a surgery or a dental extraction. Low platelet counts can increase the risk of bleeding during these procedures, so it is important to address this issue before proceeding.
Avatrombopag works by stimulating the production of platelets in the bone marrow, which helps to increase the platelet count in the blood. This can help to reduce the risk of bleeding and allow for a safer medical procedure to take place. It is typically taken orally once daily for a certain number of days leading up to the procedure.
As with any medication, there are potential side effects to be aware of when taking avatrombopag. These can include headache, fatigue, nausea, and an increase in liver enzymes. It is important to discuss any concerns or potential side effects with your healthcare provider before starting this medication.
Overall, avatrombopag can be a valuable tool in managing low platelet counts in patients with chronic liver disease who are preparing for a medical procedure. By increasing platelet production, it can help to reduce the risk of bleeding and allow for a safer and more successful outcome. If you have any questions about avatrombopag or its use, don’t hesitate to reach out to your healthcare provider for more information.
EN 
ES 
FR 
PT 
ZH